Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

Name: Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Published: 2017
License: Public Domain

Lexicon Pharmaceuticals · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

heart-failure type-2-diabetes-mellitus

heart failure, type 2 diabetes mellitus, chronic kidney diseases, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

Related documents